In Vivo Accumulation of Regulatory T Cells Using Eliglustat‐Loaded Cryogels
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202501529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Einat B Vitner und 10 weiteren Autor:innen. Beteiligte Einrichtung: John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Pyrrolidines, Cryogels, Biocompatible Materials. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swiss National Science Foundation via a Postdoc Mobility grant, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Regulatory T cells (T regs ) maintain immune homeostasis and their adoptive transfer is being widely explored to mitigate inflammatory and autoimmune conditions. Here a biomaterial is developed to accumulate T regs at a specific anatomic location to bypass the need for ex vivo T reg isolation and adoptive transfer. It is first shown that eliglustat, an FDA‐approved inhibitor of UDP‐glucose ceramide glucosyltransferase, promotes T regs from both naïve and activated CD4 + T cells in vitro. Click‐crosslinked cryogels fabricated from alginate and collagen allow for a sustained release of CXCL10 or CXCL11, and when injected in subcutaneous tissues led to the enrichment of effector and memory T cells to the scaffolds. Loading eliglustat into these cryogels significantly enhances the local accumulation of T regs in vivo. These findings demonstrate that eliglustat‐loaded cryogels offer a simple yet effective biomaterial strategy to boost T reg directly in vivo, potentially providing a targeted method to treat various inflammatory and autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.
- The Wyss Institute for Biologically Inspired Engineering Harvard University, Boston, MA, 02138, USA.
- Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, Israel, 7410001.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, 02115, USA.
ORCID-Profile: Junzhe Lou, Alexander G Stafford, David J Mooney
Förderung
- Swiss National Science Foundation via a Postdoc Mobility grant
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Vitner, E. B., Bovone, G., Jung, W. H., Lou, J., Hankenson, H., Dacus, M. T., Binenbaum, Y., Adu-Berchie, K., Stafford, A. G., Sobral, M. C., & Mooney, D. J. (2025). In Vivo Accumulation of Regulatory T Cells Using Eliglustat‐Loaded Cryogels. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501529
Vancouver
Vitner EB, Bovone G, Jung WH, Lou J, Hankenson H, Dacus MT, et al. In Vivo Accumulation of Regulatory T Cells Using Eliglustat‐Loaded Cryogels. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501529
BibTeX
@article{Vitner2025,
author = {Vitner, Einat B and Bovone, Giovanni and Jung, Wei-Hung and Lou, Junzhe and Hankenson, Hugh and Dacus, Mason T and Binenbaum, Yoav and Adu-Berchie, Kwasi and Stafford, Alexander G and Sobral, Miguel C and Mooney, David J},
title = {In Vivo Accumulation of Regulatory T Cells Using Eliglustat‐Loaded Cryogels},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202501529}
}
EUVIMED